Oxybutynin is an anticholinergic drug with an emerging role in the treatment of hyperhidrosis. Several recent studies have documented that it is effective both in focal and generalized hyperhidrosis and shows universally good response among different groups of patients regardless of age, gender, and weight. The most common adverse event is dry mouth reported by almost all patients treated. The way this might affect long-term compliance and tolerability should be better investigated in the future.

Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art / Campanati, Anna; Gregoriou, Stamatis; Kontochristopoulos, George; Offidani, Annamaria. - In: SKIN APPENDAGE DISORDERS. - ISSN 2296-9195. - 1:1(2015), p. 6-13. [10.1159/000371581]

Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art

CAMPANATI, Anna;OFFIDANI, ANNAMARIA
2015-01-01

Abstract

Oxybutynin is an anticholinergic drug with an emerging role in the treatment of hyperhidrosis. Several recent studies have documented that it is effective both in focal and generalized hyperhidrosis and shows universally good response among different groups of patients regardless of age, gender, and weight. The most common adverse event is dry mouth reported by almost all patients treated. The way this might affect long-term compliance and tolerability should be better investigated in the future.
2015
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/236757
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 20
social impact